The global market for emerging medical device technologies should grow from $81.9 billion in 2020 to $146.2 billion by 2025, at a compound annual growth rate (CAGR) of 12.3% for the period of 2020-2025.
Report Scope
Traditional medical devices include devices (e.g., metallic stents, heart valves, open procedures, general instruments, non-drug coated implantables, large endoscopes, needle-based drug delivery, lab-based diagnostics, etc.) that have been in use over the last 30 years for the treatment and management of various diseases. Emerging medical device technologies include devices and technologies (e.g., bioresorbable implants, coated implants and balloons, transcatheter heart valves (TAVR, TMVR), electrophysiology, S-ICDs, cardioMEMS, wireless monitoring, wearable devices, needle-free drug delivery, capsule endoscopes, POC tests, companion diagnostics, etc.
The format of the study is organized around the following topics -
- Emerging medical device technologies used in general surgery, cardiovascular, diabetes care, gastroenterology, medical imaging/visualization, in vitro diagnostics, neurology, ophthalmology, orthopedic, drug delivery/pain management, surgical/wound care and patient monitoring.
- Target disease demographics and cost burden.
- Regulatory structure.
- Unmet needs, market size and segmentation.
- Market drivers and restraints.
- Detailed market projections through 2024.
- Competition and market shares.
- Pricing and reimbursement.
- Marketed and pipeline (R&D) products along with descriptions, regulatory status and clinical trials.
- Observations and conclusions regarding the future of medical device technologies.
- Profiles of market participants and associations.
The Report Includes
- 111 tables
- An overview of the global markets for emerging medical device technologies
- Analyses of global market trends, with data from 2019, 2020, 2021 and projections of compound annual growth rates (CAGRs) through 2025
- Evaluation of the market's dynamics, specifically growth drivers, inhibitors, and opportunities
- Analyses of segments within the overall market including aesthetics/dermatology, cardiovascular, dental, diabetes care, gastroenterology, nephrology, urology, gynecology/women's health, medical imaging/visualization, in-vitro diagnostics, neurology, ophthalmology, orthopedic, drug delivery/pain management, surgical/wound care and patient management/monitoring
- An in-depth look at growth driving factors such as the rising prevalence of chronic diseases and related increase in disability-adjusted life years, technological advancements in medical devices, and the growing aging population
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Company profiles of the leading players operating in emerging medical device technologies market including 3M, Abbott Laboratories, Agilent Technology Inc., Boston Scientific, BioMérieux S.A., Cardinal Health, GE Healthcare, Medtronic, Novartis and Siemens Healthcare
Table of Contents
Chapter 1 Introduction
- Medical Technology
- Background
- Study Goals and Objectives
- Intended Audience
- Scope of the Report
- Methodology and Information Sources
- Geographic Breakdown
- Analyst's Credentials
- Custom Research
- Related Reports
Chapter 2 Executive Summary
- Cardiovascular
- Orthopedic
- Neurology
- Diabetes Care
- In Vitro Diagnostics
- GI and Endoscopy
- Ophthalmics
- Wound Care Management
- Drug Delivery
Chapter 3 Emerging Cardiovascular Device Technologies
- Cardiovascular Devices
- Target Diseases and Economic Burden
- Emerging Device Technologies for Heart Failure
- Heart Failure Devices
- Cardiac Resynchronization Therapy Devices
- Ventricular Assist Devices
- Wireless Heart Failure Sensor (CardioMEMS, Abbott product)
- Market Analysis
- Market Growth Drivers and Restraints
- Recent News Announcements
- Emerging Device Technologies for Electrophysiology (EP)
- Electrophysiology (EP)
- Market Analysis
- Market Growth Drivers and Restraints
- Recent News Announcements
- Emerging Device Technologies for Interventional Cardiology
- Interventional Cardiology
- Rapid Exchange PTCA Catheters
- Intravascular Ultrasound Systems (IVUS)
- Bioresorbable Vascular Scaffolds (BVS)
- Market Analysis
- Market Growth Drivers and Restraints
- Recent News Announcements
- Emerging Device Technologies for Endovascular Aneurysm/Aortic Repair (EVAR)
- Aortic Aneurysm (Abdominal and Thoracic)
- Endovascular Repair of Aortic Aneurysms
- AAA and TAA Stent Grafts
- Shift from Open Surgery to EVAR
- Market Analysis
- Market Growth Drivers and Restraints
- Recent News Announcements
- Competition in EVAR Segment
- Emerging Device Technologies for Implantable Cardioverter Defibrillators
- Conventional ICDs
- Subcutaneous ICDs
- Market for Subcutaneous ICDs
- Market Drivers and Restraints
- Recent News Announcements
- Emerging Device Technologies for Peripheral Vascular Devices
- Peripheral Vascular Devices
- Atherectomies
- Synthetic Surgical Grafts
- Drug-Coated Balloons
- Market Analysis
- Market Drivers and Restraints
- Recent News Announcements
- Emerging Technologies for Transcatheter Heart Valve Technologies
- Aortic Valve Replacement
- Transcatheter Mitral Valve Replacement
- Market Analysis
- Market Drivers and Restraints
- Recent News Announcements
- Competitive Landscape for Emerging Cardiovascular Device Technologies
- Other Cardiovascular Emerging Devices and Technologies
- Mini Heart Pump
- Sutureless Myocardial Pacing Lead
- Transcatheter Pacemaker System
- Parent Artery Reconstruction Device
Chapter 4 Emerging Device Technologies in the Orthopedic Market
- Target Diseases and Indications
- Epidemiology of Musculoskeletal Disorders
- Mortality Rates of Musculoskeletal Diseases
- Emerging Orthopedic Device Technologies
- Market Analysis
- Market Drivers and Restraints
- Recent News Announcements
- Emerging Device Technologies for Soft Tissue Fixation and Repair
- Market Analysis
- Market Drivers and Restraints
- Recent News Announcements
- Reimbursement
- Competitive Landscape in Emerging Orthopedic Device Technologies
Chapter 5 Emerging Device Technologies in Neurology
- Neurovascular Devices
- Emerging Neurovascular Device Technologies
- Recent News Announcements
- Competitive Landscape in the Neurovascular Market
- Neuromodulation Devices
- Emerging Neuromodulation Device Technologies
- Recent News Announcements
- Competitive Landscape in Neuromodulation
Chapter 6 Emerging Device Technologies in Diabetes Care
- Emerging Technologies in Diabetes Management
- Continuous Glucose Monitors
- Insulin Pumps
- Epidemiology of Diabetes
- Type 1 Diabetes
- Type 2 Diabetes
- Market Analysis
- Market Drivers and Restraints
- Recent News Announcements
- Other Emerging Device Technologies in Diabetes Care
- Remote Diabetes Monitoring
- Miniaturized Disposable Insulin Delivery Pumps
- Glucose Sensing Bio-implants for Glucose Monitoring
- Glucose Sensing Contact Lenses
- Products Using Near-Infrared (NIR) Light to Measure Glucose
- Intraperitoneal Islet Transplantation
Chapter 7 Emerging Technologies In Vitro Diagnostics
- Molecular Diagnostics
- Emerging Cancer Molecular and Companion Diagnostics
- Cancer Molecular Diagnostics
- Companion Diagnostics
- Market Analysis
- Market Drivers and Restraints
- Recent News Announcements
- Competitive Landscape in Advanced Cancer Molecular Diagnostics
- Other Emerging Diagnostics and Technologies
- Point-of-care (POC) Diagnostics
- POC and Cancer
- Market Analysis
- Market Drivers and Restraints
- Recent News Announcements
- Competitive Landscape in POC Diagnostics
- Future Outlook for POC
Chapter 8 Needle-Free Drug Delivery Technologies
- Needle-Free Drug Delivery
- Market Analysis
- Recent News Announcements
Chapter 9 Emerging Device Technologies in GI Endoscopy
- Smart Pills and Technologies
- Capsule Endoscopy
- Market Analysis
- Advantages of 3-D Endoscopy Systems
- Intragastric Balloon Systems
- Obesity and Need for Intragastric Balloons
- Market Analysis
- Recent News Announcements
Chapter 10 Other Emerging Medical Device Technologies
- IOL Implants
- Market Analysis
- Marketed and R&D Pipeline Products
- Cataracts and IOL
- Standard Monofocal vs. Premium IOLs
- Advanced Wound Management
- Advanced Wound Dressings
- Negative Pressure Wound Therapy
- Market Analysis
- Implantable Drug Diffusion Pumps
- Endoluminal Procedures
- Multiparameter Vital Signs Monitors
- Hemodialysis and Peritoneal Dialysis
- Hemodialysis
- Peritoneal Dialysis
- Biochips
- Competitive Analysis of the Biochip Market
- Ear Implants
- Market Drivers
- Mammography
- FDA Approved Devices
- Robotics and Computer-Assisted Surgery
- Surgical Planners and Simulators
- Surgical Navigation Systems
- Surgical Robots
- Digital Operating Rooms and Equipment
- Operating Tables
- Operating Room Lights
- Surgical Booms
- Operating Room Communication Systems
- Surgical Imaging Displays
- Intraoperative Diagnostics Devices
- Other Equipment
- Surgical Lasers
- Aesthetic Lasers
- Ophthalmic Lasers
- Nuclear Imaging
- Positron Emission Tomography
- Optical Imaging
- Time Domain Optical Imaging
- CT Laser Mammography
- Optical Coherence Tomography
- Scanning Laser Polarimetry
- Scanning Laser Opthalmoscopy
- Fluorescence Spectroscopy
- Digital Cameras
- Other FDA-Approved 3D and 4D Imaging Techniques
Chapter 11 COVID-19 Ushers in New Era of Medical Device Industry
- COVID-19 Impact Analysis
- FDA Awards Innovation Permission for System to Prevent People from Mechanical Ventilation
- POC Test Platform Uses Smartphone App for Rapid Detection of COVID-19
- Collaboration on COVID-19 Molecular Diagnostics Test
- Roche to Acquire Diagnostics Test Company
- Portable Ultrasound Scanner Enables Physicians to Quickly Triage COVID-19 Patients
- QuantuMDx Invests £11 Million to Develop POC COVID-19 Test Device
Chapter 12 Regulatory Structure
- United States
- Europe
- Japan
- Other Asian Countries
- China
- Hong Kong
- Korea
- Taiwan
- India
- FDA Technical Considerations
- FDA Recalls and Safety Alerts
Chapter 13 Pricing and Reimbursement
- United States
- ICD-9-CM
- ICD-10
- Europe
- Japan
- Other Asian Countries
Chapter 14 Conclusions: Outlook for Emerging Medical Device Technologies
- Developments Influencing Market
- New Innovative Solution by Platform Providers in the Market
- Adoption of Minimally Invasive and Non-Invasive Techniques
- Demographic and Economic Trends: Income Growth in Developing Markets
- Changing Structure of the Healthcare Industry
Chapter 15 Company Profiles
- 3M
- Abbott Laboratories
- Agilent Technology Inc.
- Allergan Plc
- Amarantus Bioscience Holdings Inc.
- Amd Lasers Llc
- Boston Scientific Corp.
- Biolase Inc.
- Biomerieux S.A.
- Bioness Inc.
- Biosense Webster Inc.
- Bioronik Se & Co. Kg
- Bracco
- Cardinal Health
- Colibri Heart Valve
- Cook Medical
- Cordis Corp.
- Edwards Lifesciences Corp.
- Endologix
- GE Healthcare
- HLT Medical, Inc.
- Hologic Inc.
- Illumina
- Integra Lifesciences
- Jenavalve Technology
- Karl Storz Gmbh & Co. Kg
- Livanova
- Lombard Medical Technologies
- Medtronic
- Meril Life Sciences Private Ltd.
- Microport Scientific
- Micro Interventional Devices, Inc.
- Mindray Medical International Ltd.
- Myriad Genetics Inc.
- Nidek Co. Ltd.
- Novartis International Ag
- Optotek Medical
- Quantel Medical Inc.
- Roche Diagnostics
- Siemens Healthcare
- Sklar Corp.
- Shimadzu Corp.
- Smith & Nephew
- Stryker Corp.
- Sysmex Corp.
- Terumo Corp.
- Ultrasound Technologies Ltd.
- Vigilant Biosciences
- W. L. Gore Medical Products
- Wright Medical Group Inc.
- Zealand Pharma
- Zimmer Biomet
Chapter 16 Appendix A: Industry And Professional Organizations
- American Association For Cancer Research (AACR)
- American Society For Reproductive Medicine (ASRM)
- American Society Of Clinical Oncology (ASCO)
- Center For Devices And Radiological Health (CDRH)
- Centers For Medicare & Medicaid Services (CMS)
- Eudamed
- Food And Drug Administration (FDA)
- Global Cancer Foundation
- Hormone Foundation
- International Agency For Research On Cancer (IARC)
- International Federation Of Pharmaceutical Manufacturers & Associations (IFPMA)
- International Osteoporosis Foundation (IOF)
- International Diabetes Federation (IDF)
- National Center For Biotechnology Information (NCBI)
- National Institute Of Aging (NIA)
- Pharmaceuticals And Medical Devices Agency (PMDA)
- World Cancer Research Fund International
Chapter 17 Appendix B: Abbreviations
List of Tables
Summary Table: Global Market for Emerging Medical Device Technologies, by Segment, Through 2025
Table 1: Global Incidence, Prevalence and Mortality Due to Stroke, 2019
Table 2: Worldwide Deaths from Cardiovascular Disease, by Region, 2020
Table 3: Global Deaths from CVD, 2015 and 2030
Table 4: Global Market for Emerging Heart Failure Device Technologies, by Region, Through 2025
Table 5: Global Market for Emerging Heart Failure Device Technologies, by Type, 2020-2025
Table 6: Global Market for Electrophysiology Device Technologies, by Region, Through 2025
Table 7: Global Market for Electrophysiology Device Technologies, by Type, 2020
Table 8: Global Market for Electrophysiology, by Type, 2020
Table 9: Global Market for Interventional Cardiology Device Technologies, by Region, Through 2025
Table 10: Global Market for Interventional Cardiology Device Technologies, by Type, 2020
Table 11: Epidemiology of AAA and TAA
Table 12: Global Market for EVAR and TEVAR, by Region, Through 2025
Table 13: Global Market for EVAR and TEVAR, by Aneurysm Type, 2020
Table 14: Global Market for S-ICDs, Through 2025
Table 15: Global Market for Peripheral Vascular Device Technologies, by Region, Through 2025
Table 16: Global Market for Peripheral Vascular Device Technologies, by Type, 2020
Table 17: Global Market for Transcatheter Heart Valve Technologies, by Region, Through 2025
Table 18: Global Market for Extremity Joint Reconstruction Device Technologies, by Region, Through 2025
Table 19: Global Market for Extremity Joint Reconstruction Device Technologies, by Type, 2020
Table 20: Global Market for Small Joint Reconstruction Device Technologies, by Type, 2020
Table 21: Global Market for Soft Tissue Fixation and Repair Device Technologies, by Region, Through 2025
Table 22: Global Market for Soft Tissue Fixation and Repair Device Technologies, by Type, 2020
Table 23: Target Device Technologies for Key Disease Indications
Table 24: Global Market for Neurovascular Device Technologies, by Region, Through 2025
Table 25: Global Market for Neurovascular Device Technologies, by Type, 2020
Table 26: Neuromodulation Devices and Target Disease Indications
Table 27: Global Market for Neuromodulation Device Technologies, by Region, Through 2025
Table 28: Global Market for Neuromodulation Device Technologies, by Type, 2020
Table 29: Global Percentage Increment of Diabetes, by Region, between 2015 and 2040
Table 30: Global Market for CGMs and Insulin Pumps, by Region, Through 2025
Table 31: Global Market for CGMs and Insulin Pumps, by Type, 2020
Table 32: Common Companion Diagnostic Tests and Drugs
Table 33: Global Market for Cancer Molecular Diagnostics, by Region, Through 2025
Table 34: Global Market for Cancer Molecular Diagnostics, by Type, 2020
Table 35: Global Market for Companion Diagnostics, by Region, Through 2025
Table 36: Global Market for POC Diagnostics, by Region, Through 2025
Table 37: Global Market for POC Diagnostics, by Type, 2020
Table 38: Global Market for Needle-Free Drug Delivery Technologies, by Region, Through 2025
Table 39: Global Market for Smart Pills and Technologies, Through 2025
Table 40: Trends in Obesity Composition of the Global Population, Through 2020
Table 41: U.S. Obesity and Severe Obesity vs. General Population, Through 2020
Table 42: Global Market for Intragastric Balloon Systems, Through 2025
Table 43: Global Market for IOLs, by Region, Through 2025
Table 44: Global Market for Advanced Wound Management Device Technologies, by Type, Through 2025
Table 45: Global Prevalence of Hearing Loss, by Region, 2018
Table 46: Age-Specific Probabilities of Developing Invasive Female Breast Cancer, 2013-2023
Table 47: Countries with Highest Rates of Breast Cancer, 2018
Table 48: Common Robot-Assisted, Minimally Invasive Surgeries
Table 49: Differences in Regulatory Approval in the U.S. vs. Europe
Table 50: 3M: Product Portfolio
Table 51: Abbott Laboratories: Product Portfolio
Table 52: Abbott Laboratories: Recent Developments
Table 53: Agilent Technology: Product Portfolio
Table 54: Allergan PLC: Product Portfolio
Table 55: Amarantus Bioscience Holdings Inc.: Product Portfolio
Table 56: AMD Lasers: Product Portfolio
Table 57: Boston Scientific Corp.: Product Portfolio
Table 58: Biolase: Product Portfolio
Table 59: BioMérieux S.A.: Product Portfolio
Table 60: Bioness Inc.: Product Portfolio
Table 61: Biotronik SE: Product Portfolio
Table 62: Bracco: Product Portfolio
Table 63: Cardinal Health: Product Portfolio
Table 64: Cardinal Health: Recent Developments
Table 65: Colibri Heart Valve: Product Portfolio
Table 66: Cook Medical: Product Portfolio
Table 67: Cordis Corp.: Product Portfolio
Table 68: Edwards Lifesciences: Product Portfolio
Table 69: Edwards Lifesciences: Recent Developments
Table 70: Endologix: Product Portfolio
Table 71: GE Healthcare: Product Portfolio
Table 72: GE Healthcare: Recent Developments
Table 73: HLT: Product Portfolio
Table 74: Illumina: Product Portfolio
Table 75: Illumina: Recent Developments
Table 76: Integra Lifesciences: Product Portfolio
Table 77: JenaValve Technology: Product Portfolio
Table 78: Karl Storz GmbH: Product Portfolio
Table 79: Livanova: Product Portfolio
Table 80: Lombard Medical Technologies: Product Portfolio
Table 81: Medtronic: Product Portfolio
Table 82: Medtronic: Recent Developments
Table 83: Meril Life Sciences: Product Portfolio
Table 84: Microport Scientific: Product Portfolio
Table 85: Micro Interventional Devices: Product Portfolio
Table 86: Mindray Medical International: Product Portfolio
Table 87: Myriad Genetics Inc.: Product Portfolio
Table 88: Myriad Genetics Inc.: Recent Developments
Table 89: Nidek Co. Ltd.: Product Portfolio
Table 90: Nidek Co. Ltd.: Recent Developments
Table 91: Novartis: Product Portfolio
Table 92: Optotek Medical: Product Portfolio
Table 93: Quantel Medical Inc.: Product Portfolio
Table 94: Quantel Medical Inc.: Recent Developments
Table 95: Roche Diagnostics: Product Portfolio
Table 96: Siemens Healthcare: Product Portfolio
Table 97: Sklar Corp.: Product Portfolio
Table 98: Shimadzu Corp.: Product Portfolio
Table 99: Shimadzu Corp.: Recent Developments
Table 100: Smith & Nephew: Product Portfolio
Table 101: Stryker Corp.: Product Portfolio
Table 102: Stryker Corp.: Recent Developments
Table 103: Sysmex Corp.: Product Portfolio
Table 104: Sysmex Corp.: Recent Developments
Table 105: Terumo Corp.: Product Portfolio
Table 106: Ultrasound Technologies Ltd.: Product Portfolio
Table 107: Vigilant Biosciences: Product Portfolio
Table 108: Gore Medical: Product Portfolio
Table 109: Wright Medical Group: Product Portfolio
Table 110: Zimmer Biomet: Product Portfolio
Table 111: Zimmer Biomet: Recent Developments
List of Figures
Summary Figure A: Global Projections for Selected Top Three Chronic Diseases, 2005-2030
Summary Figure: Global Market for Emerging Medical Device Technologies, by Segment, Through 2025
Figure 1: Worldwide Deaths from Cardiovascular Disease, by Region, 2020
Figure 2: Global Deaths from CVD, 2015 and 2030
Figure 3: Global Market Shares for Emerging Heart Failure Device Technologies, by Region, 2020
Figure 4: Global Market Shares of Emerging Heart Failure Device Technologies, by Type, 2020
Figure 5: Global Market Shares of Electrophysiology Device Technologies, by Region, 2020
Figure 6: Global Market Shares of Electrophysiology Device Technologies, by Type, 2020
Figure 7: Global Market Shares of Electrophysiology, by Type, 2020
Figure 8: Global Market Shares of Interventional Cardiology Device Technologies, by Region, 2020
Figure 9: Global Market Shares of Interventional Cardiology Device Technologies, by Type, 2020
Figure 10: Global Market Shares of EVAR and TEVAR, by Region, 2020
Figure 11: Global Market Shares for EVAR and TEVAR, by Aneurysm Type, 2020
Figure 12: Global Market Shares of Peripheral Vascular Device Technologies, by Region, 2020
Figure 13: Global Market Shares of Peripheral Vascular Device Technologies, by Type, 2020
Figure 14: Global Market Shares of Transcatheter Heart Valve Technologies, by Region, 2020
Figure 15: Global Market Shares of Leading Companies in Emerging Cardiovascular Device Technologies, 2019
Figure 16: Number of U.S. Citizens Aged 45 and Above with Musculoskeletal Disorders, 2015-2040
Figure 17: Global Market Shares of Extremity Joint Reconstruction Device Technologies, by Region, 2020
Figure 18: Global Market Shares of Extremity Joint Reconstruction Device Technologies, by Type, 2020
Figure 19: Global Market Shares of Small Joint Reconstruction Device Technologies, by Type, 2020
Figure 20: Global Market Shares of Soft Tissue Fixation and Repair Device Technologies, by Region, 2020
Figure 21: Global Market Shares of Soft Tissue Fixation and Repair Device Technologies, by Type, 2020
Figure 22: Global Market Shares of Leading Companies in Emerging Cardiovascular Device Technologies, 2019
Figure 23: Global Market Shares of Neurovascular Device Technologies, by Region, 2020
Figure 24: Global Market Shares of Neurovascular Device Technologies, by Type, 2020
Figure 25: Global Market Shares of Cerebral Aneurysm Device Technologies, by Type, 2020
Figure 26: Global Market Shares of Neurovascular Device Technologies, by Leading Companies, 2019
Figure 27: Global Market Shares of Neuromodulation Device Technologies, by Region, 2020
Figure 28: Global Market Shares of Neuromodulation Device Technologies, by Type, 2020
Figure 29: Global Market Shares of Neuromodulation Devices and Technologies, by Leading Companies, 2019
Figure 30: Global Number of Adults with Diabetes, 2015 and 2040
Figure 31: Global Share of Percentage Increment of Diabetes, by Region, between 2015 and 2040
Figure 32: Global Market Shares of CGMs and Insulin Pumps, by Region, 2020
Figure 33: Global Market Shares of CGMs and Insulin Pumps, by Type, 2020
Figure 34: Global Market Shares of CGM Systems and Insulin Pumps, by Leading Companies, 2019
Figure 35: Rise in Number of Cancer Patients, 2012 and 2030
Figure 36: Global Deaths from Cancer, 2015 and 2030
Figure 37: Global Market Shares of Cancer Molecular Diagnostics, by Region, 2020
Figure 38: Global Market Shares of Cancer Molecular Diagnostics, by Type, 2020
Figure 39: Global Market Shares of Companion Diagnostics, by Region, 2020
Figure 40: Leading Companies’ Shares of Global Market for Companion Diagnostics and Technologies, 2019
Figure 41: Global Market Shares of POC Diagnostics, by Region, 2020
Figure 42: Global Market Shares of POC Diagnostics, by Type, 2020
Figure 43: Global Market Shares of Molecular Diagnostics Device Technologies, by Leading Companies, 2019
Figure 44: Global Market Shares of Needle-Free Drug Delivery Technologies, by Region, 2020
Figure 45: Timeline of Biochip Market
Figure 46: Shares of Leading Companies in the Global Market for Biochips, 2019
Figure 47: Global Prevalence of Hearing Loss, 2018
Figure 48: Factors Affecting Breast Cancer Risk in Women
Figure 49: Countries with Highest Rates of Breast Cancer, 2018
Figure 50: Shares of Global Market for Roboticare, by Technology, 2018 and 2029
Figure 51: Annual Revenues for Robot-Assisted, Minimally Invasive Surgery Market, 2015-2025
Figure 52: Cost Breakdown for Hybrid Operating Rooms, 2020
Figure 53: Cloud Computing in Medical and Surgical Imaging
Figure 54: Rising Trends in Healthcare Spending, by Institution, 2015-2040
Samples
LOADING...
Executive Summary
Companies that are looking to invest funds in the medical device sector ought to strongly consider high-growth segments such as electrophysiology, bioresorbable vascular scaffold (BVS), transcatheter heart valve therapy and drug-coated balloons (DCB) in the cardiovascular market; point-of-care diagnostics (POCs)q, companion diagnostics and advanced cancer molecular diagnostics in the in vitro diagnostics market; and smart pills (capsule endoscopes, etc.) in the GI endoscopy market. Most of these segments are expected to have double-digit growth rates in the next five years. The increasing burden of diseases such as cardiovascular diseases, diabetes and cancer, and the growing adoption of advanced medical technologies are the key growth drivers.
The rising demand for imaging in the diagnosis and monitoring of chronic diseases is a major contributor to the growth of the global market for emerging medical devices. A shift toward minimally invasive procedures and rising adoption of hybrid operating rooms are also providing traction for the market. Secondary factors such as the increasing number of surgical procedures and high growth in patient care devices are also driving the market.
There is increased demand for advanced medical devices in cardiology and oncology. Heart valve replacement is the most common procedure in cardiology. Transcatheter aortic valve replacement is a minimally invasive heart valve replacement procedure. Positioning the new heart valve is a concern for surgeons. Due to the importance of positioning, surgeons prefer 3-D angiography imaging devices to view the anatomy during the placement of heart valves. As the number of heart surgeries increases worldwide, the use of advanced medical devices is expected to increase over the forecast period.
According to the World Health Organization (WHO), cardiovascular diseases, cancers, respiratory diseases and diabetes account for more than 80% of all premature non-communicable disease (NCD) deaths. NCDs claim 40 million victims each year and account for approximately 70% of global deaths. 3-D imaging devices are increasingly used in oncology and radiology.
Companies Mentioned
- 3M
- Abbott Laboratories
- Agilent Technology Inc.
- Allergan Plc
- Amarantus Bioscience Holdings Inc.
- AMD Lasers LLC
- American Association For Cancer Research (AACR)
- American Society For Reproductive Medicine (ASRM)
- American Society Of Clinical Oncology (ASCO)
- Biolase Inc.
- Biomerieux S.A.
- Bioness Inc.
- Bioronik Se & Co. Kg
- Biosense Webster Inc.
- Boston Scientific Corp.
- Bracco
- Cardinal Health
- Center For Devices and Radiological Health (CDRH)
- Centers For Medicare & Medicaid Services (CMS)
- Colibri Heart Valve
- Cook Medical
- Cordis Corp.
- Edwards Lifesciences Corp.
- Endologix
- Eudamed
- Food And Drug Administration (FDA)
- GE Healthcare
- Global Cancer Foundation
- HLT Medical, Inc.
- Hologic Inc.
- Hormone Foundation
- Illumina
- Integra Lifesciences
- International Agency For Research On Cancer (IARC)
- International Diabetes Federation (IDF)
- International Federation Of Pharmaceutical Manufacturers & Associations (IFPMA)
- International Osteoporosis Foundation (IOF)
- Jenavalve Technology
- Karl Storz Gmbh & Co. Kg
- Livanova
- Lombard Medical Technologies
- Medtronic
- Meril Life Sciences Private Ltd.
- Micro Interventional Devices, Inc.
- Microport Scientific
- Mindray Medical International Ltd.
- Myriad Genetics Inc.
- National Center For Biotechnology Information (NCBI)
- National Institute Of Aging (NIA)
- Nidek Co. Ltd.
- Novartis International Ag
- Optotek Medical
- Pharmaceuticals And Medical Devices Agency (PMDA)
- Quantel Medical Inc.
- Roche Diagnostics
- Shimadzu Corp.
- Siemens Healthcare
- Sklar Corp.
- Smith & Nephew
- Stryker Corp.
- Sysmex Corp.
- Terumo Corp.
- Ultrasound Technologies Ltd.
- Vigilant Biosciences
- W. L. Gore Medical Products
- World Cancer Research Fund International
- Wright Medical Group Inc.
- Zealand Pharma
- Zimmer Biomet
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 219 |
Published | May 2021 |
Forecast Period | 2020 - 2025 |
Estimated Market Value ( USD | $ 81.9 Billion |
Forecasted Market Value ( USD | $ 146.2 Billion |
Compound Annual Growth Rate | 12.3% |
Regions Covered | Global |
No. of Companies Mentioned | 69 |